Information Provided By: 
Fly News Breaks for March 2, 2018
SPLK
Mar 2, 2018 | 09:32 EDT
BMO Capital analyst Keith Bachman raised his price target on Splunk to $112 after an "impressive" quarter of results driven by the positive momentum in revenues and billings. The analyst attributes the improved performance to the customers "increasingly standardizing" and expanding Splunk products through multiple use cases, which he says is adding to his confidence in FY20 revenue targets. Bachman keeps his Outperform rating on Splunk.
News For SPLK From the Last 2 Days
SPLK
Apr 23, 2024 | 08:31 EDT
New option listings for April 23rd include Express Inc (EXPRQ). Option delistings effective April 23rd include PGT Innovations Inc (PGTI), NGM Biopharmaceuticals Inc (NGM), Karuna Therapeutics Inc (KRTX), KINNATE BIOPHARMA INC (KNTE), Daseke Inc (DSKE), Tritium Dcfc Ltd (DCFC), Xtrackers MSCI All China Equity ETF (CN), CymaBay Therapeutics Inc (CBAY), Alteryx Inc (AYX), XTRACKERS MSCI CHINA A INCLUSION EQUITY ETF (ASHX), Recro Pharma, Inc. (SCTL), Splunk Inc (SPLK), and Textainer Group Holdings Limited (TGH).
